Feb 25, 2020 - Health

America's addiction treatment misses the mark

Illustration: Aïda Amer/Axios

Addiction treatment in the U.S. is critically necessary yet deeply flawed.

The big picture: Drug overdoses kill tens of thousands of Americans a year, but treatment is often inaccessible. The industry is also riddled with subpar care and, in some cases, fraud.

"We have a remarkably fragmented and highly strained treatment system, which has contributed to the shocking rates of overdose that we see," said Caleb Alexander of Johns Hopkins Bloomberg School of Public Health.

  • As Reuters recently reported, only 15% of patients in residential drug treatment centers received medication-assisted treatment in 2015, although it's widely agreed that anti-addiction medicines are the most effective treatment for opioid abuse.

Not only do treatment centers often lack proven treatment methods, but they also often use ineffective ones.

  • As Vox's German Lopez has reported, there's really no way for patients to know whether an addiction treatment program is any good. Insurers don't communicate well about quality, and regulators don't do a good job of monitoring it.
  • "Little in medicine is as ill defined or as anecdotal as addiction treatment. Most rehab centers are not hospitals. The counsellors are often not psychologists. The medical directors can submit instructions from a distance," Colton Wooten writes in the New Yorker, recounting his own haunting experience with rehab.
  • Fraud has also been a problem. For example, in Florida, "sober homes" for people in recovery have been caught scamming insurance companies time and again.

"There is a massive for-profit industry that operates separate and outside of established medicine, relying on group therapy, 12-steps, counseling, etc. while eschewing best medical practices," said Zach Siegel, a journalism fellow at Northeastern University School of Law.

Insurance companies are required to cover mental health on par with their physical health coverage, but have often ignored those rules.

  • That can result in families paying huge out-of-pocket costs for treatment, or people suffering from addiction simply going untreated.
  • Additionally, as Vox's Lopez writes, "insurers often don’t know what good or necessary treatment is, because they’ve remained outside the field for so long, and so much of what is out there is of uncertain quality."
  • That means high-quality treatment centers aren't necessarily the ones that are covered by insurance.

The bottom line: Providers, insurers and regulators all need to do a lot more if we're going to have a functioning addiction treatment system.

Go deeper: How to change treatment for opioid addiction

Go deeper

It may be time to waive patients' costs for coronavirus treatment

Illustration: Sarah Grillo/Axios

It may soon be time for the U.S. to take an unprecedented step and waive the costs of treatment for the new coronavirus, for everyone.

Where it stands: Insurers have already waived the cost of testing for many patients. But if hospitals are deluged with coronavirus cases, as expected, it may also be time to look at the substantially higher cost of treatment.

Go deeperArrowMar 19, 2020 - Health

The U.S. is still taking on measles during the coronavirus threat

A patient receiving the measles vaccine on Aug. 28, 2019. Photo: Julian Stratenschulte/picture alliance via Getty Images

The U.S. is still grappling with old diseases like measles — as well as enduring problems like addiction and heart disease — even as it tries to combat new threats like the coronavirus, the Washington Post reports with Kaiser Health News.

Why it matters: While we race for new treatments in the wake of new threats, we're also beset by plenty of problems we know how to solve. Declining vaccination rates, for example, are allowing once-vanquished diseases to come roaring back, and holes in addiction treatment keep people at risk.

Scoop: Bayer to donate potential coronavirus drug to U.S.

Nurses screen patients for COVID-19 virus testing at a drive-up location outside Medstar St. Mary's Hospital on March 17, 2020 in Leonardtown, Maryland. Photo: Win McNamee/Getty Images

Pharma company Bayer will soon make a large donation to the U.S. government of a drug that has shown some promise in helping patients suffering from the novel coronavirus, according to a senior Health and Human Services official and another source with direct knowledge.

Why it matters: It doesn't hurt to have a potential treatment on hand, but we're still a very long way from having an approved, clinically tested treatment for the coronavirus.

Go deeperArrowMar 18, 2020 - Health